Clinical Policy Title: Computerized gait analysis
|
|
- Marilynn French
- 6 years ago
- Views:
Transcription
1 Clinical Policy Title: Computerized gait analysis Clinical Policy Number: Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: June 17, 2015 Next Review Date: May 2016 Policy contains: Specialized laboratories. Cerebral palsy. Spina bifida. Orthopedic surgery. ABOUT THIS POLICY: AmeriHealth Caritas Louisiana has developed clinical policies to assist with making coverage determinations. AmeriHealth Caritas Louisiana clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional societies, and peer-reviewed professional literature. These clinical policies, along with other sources, such as plan benefits and state and federal laws and regulatory requirements, including any state- or plan- specific definition of medically necessary, and the specific facts of the particular situation are considered by AmeriHealth Caritas Louisiana when making coverage determinations. In the event of conflict between this clinical policy and plan benefits and/or state or federal laws and/or regulatory requirements, the plan benefits and/or state and federal laws and/or regulatory requirements shall control. AmeriHealth Caritas Louisiana clinical policies are for informational purposes only and not intended as medical advice or to direct treatment. Physicians and other health care providers are solely responsible for the treatment decisions for their patients. AmeriHealth Caritas Louisiana clinical policies are reflective of evidence-based medicine at the time of review. As medical science evolves, AmeriHealth Caritas Louisiana will update its clinical policies as necessary. AmeriHealth Caritas Louisiana clinical policies are not guarantees of payment. Coverage policy AmeriHealth Caritas Louisiana considers computerized gait analysis to be investigational and therefore, not medically necessary. Limitations: None. Alternative covered services: Observational clinical gait analysis. Background Gait and balance disorders are common in the elderly (where they constitute a significant contributor to falls), after orthopedic surgery, and in neurodevelopmental disorders, such as spina bifida and cerebral palsy. The clinical heterogeneity of gait disorders reflects the large and complex neuromuscular systems involved and the vulnerability of walking to neurologic disease at every level.
2 Neurodevelopmental disorders are impairments of growth and development of the brain and central nervous system occurring in infancy or childhood that unfold during the rest of life. These disorders have widespread effects that can impact such things as learning, memory and other cognitive functions, as well as voluntary muscle control (coordination, mobility, speech articulation). Neurodevelopmental disorders are attributable to genetics, metabolic or infectious diseases, physical trauma, and toxic or other environmental exposures. Specific examples covered by the reviews tabulated on pages 2 and 3 are: Cerebral palsy (CP) A group of permanent disorders causing physical disability (paralysis or uncontrollable muscle movements) and sometimes problems with sensation, depth perception and communication. Most cases are caused by damage to the motor cortex during pregnancy or childbirth, although a few are genetic. Improved prenatal and newborn care has decreased incidence to approximately two per 1,000 live births. CP is not treatable per se, but managed through problem-focused physical, occupational, and speech therapies, along with specialized education. Improved delivery, pre- and neonatal care have decreased incidence to approximately two per 1,000 live births. remove (duplicate) Spina bifida A congenital disorder caused by incomplete closure of the embryonic neural tube, which results in malformation of some vertebrae, usually in the lower thoracic and lumbar areas of the spine, along with protrusion of the spinal cord through an opening in the bone and myelomeningocele. While some mild forms of spina bifida are occult (not clinically evident), many forms are associated with nerve damage (e.g., ambulatory problems, loss of sensation, or skeletal malformations, such as hip dislocation or scoliosis, and bladder or bowel malfunction). Hydrocephalus may also accompany spina bifida, and along with it attention deficits and poor academic performance. Computerized or instrumented gait analysis is a technique used for certain conditions. Providers have historically diagnoses and classified gait by observation but common adaptation patterns to failing gaits, threatened stability, and declining performance make these classifications overlapping or otherwise lacking in discrimination. Standardized gait analysis in specialized laboratories equipped with cameras, floor sensors, and other equipment has been developed in response to the problems inherent in descriptive classification. Gait analyses are used to diagnose, plan treatments and evaluate outcomes. Definitions include: Comprehensive computer-based motion analysis by videotaping; three-dimensional kinematics; and dynamic plantar pressure measurements during walking. Dynamic surface electromyography of multiple muscles during walking or other functional activities. 2
3 Diagnostic testing has been the subject of much methodological discussion, summarized by Muir Gray (1997) and Sackett (1991). Understanding diagnostic test analysis through the progression of research is important to interpretation of the literature, and to rational clinical selection and use of tests. Briefly, evaluation of a diagnostic technology entails five levels (Banta and Luce, 1993): 1. Technical evaluation The technical output gives accurate information concerning the structure of the body part imaged. 2. Diagnostic accuracy This output concerns information that potentially improves the clinician s ability to diagnose disease and assess the patient s prognosis. 3. Diagnostic impact The information can alter plans for additional diagnostic tests. 4. Therapeutic impact The information can lead to changes in therapeutic plans for patients. 5. Health impact The end result may be improved patient outcome. Methods Searches (April 2014 to May 2014): AmeriHealth Caritas Louisiana searched PubMed and the databases of: UK National Health Services Centre for Reviews and Dissemination. Agency for Healthcare Research and Quality Guideline Clearinghouse and evidence-based practice centers. The Centers for Medicare & Medicaid Services (CMS). Search terms were gait disorders, and diagnosis. Included were: Systematic reviews, which pool results from multiple studies to achieve larger sample sizes and greater precision of effect estimation than in smaller primary studies. Systematic reviews use predetermined transparent methods to minimize bias, effectively treating the review as a scientific endeavor, and are thus rated highest in evidence-grading hierarchies. Guidelines based on systematic reviews. Economic analyses, such as cost-effectiveness, and benefit or utility studies (but not simple cost studies), reporting both costs and outcomes sometimes referred to as efficiency studies which also rank near the top of evidence hierarchies. Overview of the literature: systematic reviews/guidelines and economic analyses for computerized gait analysis; reverse chronological order and then alphabetically by first author Findings: Computerized three-dimensional gait analysis is promising for identifying individuals in need of preventive measures (for falling) or rehabilitation (for walking) but is a complex process producing vast amounts of data. 3
4 Research is still defining those gait measures with the sensitivity and specificity likely to make them clinically useful. Thus, research is currently confined to the diagnostic accuracy level outlined above. While studies often show that gait analysis impacts decisions, many studies fail to address impacts on patient outcomes. Citation Health Net (2014) Wren and Ostuka (2013) Cincinnati Children s Hospital Medical Center (2011) Hamacher (2011) Wren and Gorton (2011) Content, Methods, Recommendations Computerized gait analysis: Observational analysis is sufficient to characterize most gait pathologies. However, with increasing walking complexity, objective analysis may become necessary. No CMS National or Local Coverage Determinations listed. Patient outcomes if surgeon had/didn t have results of gait analysis: 156 subjects, children with cerebral palsy For 83 and 73, surgeon did/did not receive the patient gait analysis report. Outcomes assessed before surgery and 1.3 years post-operatively. Child Health Questionnaire much better in 56% with report, 38% without. Pediatric Outcomes Data Collection Instrument for upper extremity showed better outcomes in patients whose surgeon received gait analysis report. Idiopathic toe walking in children and young adults: Does not address computerized gait analysis. Kinematic measures for gait stability in the elderly: Relevant original articles, 1980-Mar /9889 studies included. Best for distinguishing fallers from non-fallers: linear variability of temporal measures for swing and stance; old versus young adults: width and stride velocities. Linear and non-linear measures of foot-time series during gait predict healthy versus fallprone; Biomechanical measures promising for identifying individuals at risk of falling and can be obtained by relatively low cost clinical assessment. Efficacy of clinical gait analysis 1528 references, addressed technical accuracy efficacy. 89 addressed diagnostic accuracy efficacy. 11 addressed diagnostic and therapeutic efficacy. 7 addressed patient outcomes efficacy. 1 addressed societal efficacy. Strong evidence of efficacy overall. Patient outcome/cost-effectiveness efficacy found, without randomized controlled trials. 4
5 Citation Sharma (2009) Wren and Kalisvaart (2009) Content, Methods, Recommendations Factors influencing early rehab after total hip arthroplasty: CCTs, trials (2060 subjects). Preoperative physical therapy, aggressive post-operative pain control, and minimally invasive surgical procedures (but not gait analysis) improved functional recovery. Effects of preoperative gait analysis on costs 462 subject with CP, 313/149 with/without gait analysis preoperatively. 11% and 32% of gait/non-gait subjects had additional surgeries. Costs per person-year were $916/$3009 for gait/non-gait subjects. Tomie (1997) Alberta Heritage Foundation Hayes (2006) Cerebral palsy, spina bifida, orthopedic disorders: Gait analysis is potentially useful in the management of walking disabilities but its efficacy has not been established. Rehabilitation of children with cerebral palsy and spina bifida: Relevant peer-reviewed English-language clinical studies, 1996 October studies: prospective controlled/comparative (6); prospective uncontrolled (1); case series (1); retrospective (4) CP subjects; 28 spina bifida; post-surgical orthopedic (57); surgical decisions or treatment planning (87). Most studies used Vicon motion analysis systems but number, placement of monitors, and data collect varied; overall, heterogeneity precluded analysis of consistency among outcomes. Sample sizes too small for valid comparisons among study groups and no usable orthopedic patient data. Limited evidence that gait analysis can distinguish normal versus abnormal gaits and may influence clinical decisions but insufficient evidence to assess impact on continuum of care or outcomes. Glossary Hydrocephalus An abnormal accumulation of cerebrospinal fluid in the ventricles or cavities within the brain. It can cause increased pressure and neurological symptoms such as convulsions, vision abnormalities, or headache. It can be treated by shunting the excess fluid by catheter into other body cavities, but this does not resolve neurologic defects. Myelomeningocele A protuberance of the spinal cord and covering tissues (meninges) through the spine defect in spina bifida. Since many individuals with disabling spina bifida also have myelomeningocele, the terms are sometimes (incorrectly) used interchangeably. 5
6 Scoliosis Curvature of the spine from side to side, forming an S shape on radiographs. Sensitivity The proportion of people with the disease who have a positive test result. Specificity The proportion of people without a disease who have a negative test result. Related Policies AmeriHealth Caritas Louisiana Utilization Management program description. References Professional society guidelines: Banta HD, Luce BR. Health Care Technology and its Assessment: An International Perspective. New York: Oxford University Press, 1993: 384 Pages. Cincinnati Children s Hospital Medical Center. Evidence-based care guideline for management of idiopathic toe walking in children and young adults ages 2 through 21 years. Cincinnati (OH): Cincinnati Children s Hospital Medical Center Hayes, Inc. Computerized gait analysis for cerebral palsy, spina bifida, and orthopedic disorders. Lansdale: Hayes, Inc. Directory Publication Tomie J-A, Hailey D. Computerized gait analysis in the rehabilitation of children with cerebral palsy and spina bifida. Alberta Heritage Foundation for Medical Research (AHFMR)1997:38. Peer-reviewed references: Cimolin V, Galli M. Summary measures for clinical gait analysis: a literature review. Gait and Posture 2014;39(4): Dobson F, Morris ME, et al. Gait classification in children with cerebral palsy: a systematic review. Gait and Posture 2007 Jan;25(1): Ewen AM, Stewart S, St. Clair GA, Kashyap SN, Caplan N. Post-operative gait analysis in total hip replacement patients: a review of the current literature and meta-analysis. Gait and Posture 2012;36(1):1 6. Hamacher D, Singh NB, Van Dieën JH, Heller MO, Taylor WR. Kinematic measures for assessing gait stability in elderly individuals: a systematic review. Journal of the Royal Society Interface 2011: Hogan N, Coote S. Therapeutic interventions in the treatment of people with multiple sclerosis with mobility problems: a literature review. Physical Therapy Reviews 2009;14(3): Honaker JA. Clinical use of the gaze stabilization test for screening risk in community-dwelling older adults. Otology and Neurology 2013 Jun;34(4):
7 McClellan JA, Webster KA, Feller JA. Gait analysis of patients following total knee replacement: a systematic review. The Knee 2007 Aug: Sharma V, Morgan PM, Cheng EY. Factors influencing early rehabilitation after total hip arthroplasty: a systematic review. Clinical Orthopedics and Related Research 2009;467(6): Wren TA, Elihu KJ et al. Differences in implementation of gait analysis recommendations based on affiliation with a gait laboratory. Gait and Posture 2013 Feb;37(2): Wren TA, Otsuka NY et al. Outcomes of lower extremity orthopedia surgery in ambulatory children with Cerebral Palsy with and without gait analysis: results of a randomized controlled trial. Gait and Posture 2013 Jun;38(2): Wren TA, Gorton GE, et al. Efficacy of clinical gait analysis: a systematic review. Gait and Posture 2011 Jun;34(2): Wren TA, Kalisvaart MM et al. Effects of preoperative gait analysis on costs and amount of surgery. Journal of Pediatric Orthopedics 2009 Sep;29(6): Clinical trials: Reviews in the evidence table (page 3 to page 6) cover trials published through CMS National Coverage Determinations (NCDs): There are no CMS NCDs as of the policy update. Local Coverage Determinations (LCDs): There are no LCDs as of the policy update. Commonly submitted codes Below are the most commonly submitted codes for the service(s)/item(s) subject to this policy. This is not an exhaustive list of codes. Providers are expected to consult the appropriate coding manuals and bill accordingly. CPT/HCPCS codes Code Description Comprehensive computer-based motion analysis by videotaping and 3- D kinematics Comprehensive computer-based motion analysis by video-taping and 3-D kinematics; with dynamic plantar pressure measurements during walking Dynamic surface electromyography, during walking or other functional activities, 1-12 muscles 7
8 96003 Dynamic fine wire electromyography, during walking or other functional activities, 1 muscle Review and interpretation by physician or other qualified health care professional of comprehensive computer-based motion analysis dynamic plantar pressure measurements, dynamic surface electromyography during walking or other functional activities, and dynamic fine wire electromyography, with written report ICD-9 Codes Description Gait disorder Cerebral palsy Spina bifida ICD-10 Code ICD-10 Description G80.0 Spastic quadriplegic cerebral palsy G80.1 Spastic diplegic cerebral palsy G80.2 Spastic hemiplegic cerebral palsy G80.8 Other cerebral palsy Q05.0 Cervical spina bifida with hydrocephalus Q05.1 Thoracic spina bifida with hydrocephalus Q05.2 Lumbar spina bifida with hydrocephalu Q05.3 Sacral spina bifida with hydrocephalus Q05.4 Unspecified spina bifida with hydrocephalus Q05.5 Cervical spina bifida without hydrocephalus Q05.6 Thoracic spina bifida without hydrocephalus Q05.7 Lumbar spina bifida without hydrocephalus Q05.8 Sacral spina bifida without hydrocephalus Q05.9 Spina bifida, unspecified Q07.00 Arnold-Chiari syndrome without spina bifida or hydrocephalus Q07.01 Arnold-Chiari syndrome with spina bifida Q07.02 Arnold-Chiari syndrome with hydrocephalus Q07.03 Arnold-Chiari syndrome with spina bifida and hydrocephalus R26.0 Ataxic gait R26.1 Paralytic gait R26.81 Unsteadiness on feet R26.89 Other abnormalities of gait and mobility R26.9 Unspecified abnormalities of gait and mobility 8
Clinical Policy Title: Computerized gait analysis
Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: June 22, 2017 Next Review Date:
More informationClinical Policy Title: Computerized gait analysis
Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: May 1, 2018 Next Review Date:
More informationMOTION DIAGNOSTIC IMAGING (CMDI)/ GAIT ANALYSIS
Page: 1 of 5 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title COMPUTERIZED MOTION DIAGNOSTIC IMAGING (CMDI)/ GAIT ANALYSIS Policy Number 2.01.13 Category Technology Assessment Effective Date
More informationClinical Policy Title: Cardiac rehabilitation
Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review
More informationClinical Policy Title: Strep testing
Clinical Policy Title: Strep testing Clinical Policy Number: 07.01.09 Effective Date: December 1, 2017 Initial Review Date: October 19, 2017 Most Recent Review Date: November 16, 2017 Next Review Date:
More informationClinical Policy Title: Genicular nerve block
Clinical Policy Title: Genicular nerve block Clinical Policy Number: 14.01.10 Effective Date: October 1, 2017 Initial Review Date: September 21, 2017 Most Recent Review Date: October 19, 2017 Next Review
More informationClinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden
Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next
More informationIntrathecal Baclofen for CNS Spasticity
Intrathecal Baclofen for CNS Spasticity Last Review Date: October 13, 2017 Number: MG.MM.ME.31bC7 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary
More informationClinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering)
Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Number: 17.02.02 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent
More informationClinical Policy Title: Discography
Clinical Policy Title: Discography Clinical Policy Number: 03.01.01 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2017 Next Review Date: October
More informationClinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening
Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent
More informationClinical Policy Title: Zoster (shingles) vaccine
Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Number: 18.02.10 Effective Date: June 1, 2018 Initial Review Date: April 10, 2018 Most Recent Review Date: May 1, 2018 Next Review Date:
More informationClinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden
Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:
More informationClinical Policy Title: Bone growth stimulators for non-healing fractures
Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Number: 14.02.03 Effective Date: January 1, 2015 Initial Review Date: July 16, 2014 Most Recent Review Date: March
More informationClinical Policy Title: Breast cancer index genetic testing
Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Number: 02.01.22 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2016
More informationClinical Policy Title: Ketamine for treatment-resistant depression
Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Number: 00.02.13 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next
More informationClinical Policy Title: Subtalar arthroereisis (implant)
Clinical Policy Title: Subtalar arthroereisis (implant) Clinical Policy Number: 14.03.05 Effective Date: April 1, 2017 Initial Review Date: August 17, 2016 Most Recent Review Date: September 21, 2017 Next
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next
More informationClinical Policy Title: Ear tubes (tympanostomy)
Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 11.03.05 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: September 21, 2017 Next
More informationClinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening
Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent
More informationClinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab
Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Number: 01.01.03 Effective Date: January 1, 2016 Initial Review Date: September 16, 2015 Most Recent
More informationGAIT ANALYSIS. Policy Number: OUTPATIENT T2 Effective Date: June 1, Related Policies None
GAIT ANALYSIS UnitedHealthcare Oxford Clinical Policy Policy Number: OUTPATIENT 039.11 T2 Effective Date: June 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF BUSINESS/PRODUCTS...
More informationClinical Policy Title: Genetic tests for Duchenne muscular dystrophy
Clinical Policy Title: Genetic tests for Duchenne muscular dystrophy Clinical Policy Number: 02.01.23 Effective Date: February 1, 2017 Initial Review Date: January 18, 2017 Most Recent Review Date: January
More informationClinical Policy Title: Frenectomy for ankyloglossia
Clinical Policy Title: Frenectomy for ankyloglossia Clinical Policy Number: 11.03.03 Effective Date: October 1, 2014 Initial Review Date: April 16, 2014 Most Recent Review Date: May 18, 2016 Next Review
More informationAmerican Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights
American Board of Physical Medicine & Rehabilitation Part I Curriculum & Weights Neurologic Disorders 30% Stroke Spinal Cord Injury Traumatic Brain Injury Neuropathies a) Mononeuropathies b) Polyneuropathies
More informationOrthopedic Issues in Children with Special Healthcare Needs
Orthopedic Issues in Children with Special Healthcare Needs Kathryn A Keeler, MD Assistant Professor University of Missouri-Kansas City School of Medicine, Department of Orthopaedic Surgery and Department
More informationComputerized gait analysis is considered medically necessary when BOTH of the following criteria are met:
Medical Coverage Policy Effective Date... 4/15/2018 Next Review Date... 4/15/2019 Coverage Policy Number... 0315 Gait Analysis Table of Contents Coverage Policy... 1 Overview... 1 General Background...
More informationNYEIS Version 4.3 (ICD) ICD - 10 Codes Available in NYEIS at time of version launch (9/23/2015)
D82.1 Di George's syndrome E63.9 Nutritional deficiency, unspecified E70.21 Tyrosinemia E70.29 Other disorders of tyrosine metabolism E70.30 Albinism, unspecified E70.5 Disorders of tryptophan metabolism
More informationClinical Policy Title: Vacuum assisted closure in surgical wounds
Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Number: 17.03.00 Effective Date: September 1, 2015 Initial Review Date: June 16, 2013 Most Recent Review Date: August 17,
More informationClinical Policy Title: Radiofrequency ablation treatment for spine pain
Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Number: 03.02.02 Effective Date: June 1, 2013 Initial Review Date: March 21, 2013 Most Recent Review Date: March
More informationClinical Policy Title: Uvulopalatopharyngoplasty
Clinical Policy Title: Uvulopalatopharyngoplasty Clinical Policy Number: 10.03.05 Effective Date: October 1, 2015 Initial Review Date: June 17, 2015 Most Recent Review Date: July 20, 2017 Next Review Date:
More informationClinical Policy Title: Epidermal nerve fiber density testing
Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: 09.01.12 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19,
More informationClinical Policy Title: Pharmacogenomic tests for psychiatric medications
Clinical Policy Title: Pharmacogenomic tests for psychiatric medications Clinical Policy Number: 02.02.01 Effective Date: October 1, 2015 Initial Review Date: April 15, 2015 Most Recent Review Date: May
More informationDISORDERS OF THE NERVOUS SYSTEM
DISORDERS OF THE NERVOUS SYSTEM Bell Work What s your reaction time? Go to this website and check it out: https://www.justpark.com/creative/reaction-timetest/ Read the following brief article and summarize
More informationClinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)
Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most
More informationDoes not intend to discuss commercial products or services. Does not intend to discuss non-fda approved uses of products/providers of services.
Date: 3/17/2017 Lecture title: Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele Anastasia Arynchyna, MPH, CCRP Clinical Research Manager, Department
More informationIMPORTANT REMINDER DESCRIPTION
Medical Policy Manual Medicine, Policy No. 107 Gait Analysis Next Review: March 2019 Last Review: March 2018 Effective: April 1, 2018 IMPORTANT REMINDER Medical Policies are developed to provide guidance
More informationClinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation
Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation Clinical Policy Number: 04.01.04 Policy contains: Effective Date: January 1, 2016 Initial Review Date September
More informationClinical Policy Title: Cryoneurolysis
Clinical Policy Title: Cryoneurolysis Clinical Policy Number: 09.02.08 Effective Date: May 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review Date: April 19, 2017 Next Review Date: April 2018
More informationMP.094.MH Transcutaneous Electrical Nerve Stimulators
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.094.MH Transcutaneous Electrical Nerve Stimulators This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP
More informationClinical Policy Title: Home phototherapy for hyperbilirubinemia
Clinical Policy Title: Home phototherapy for hyperbilirubinemia Clinical Policy Number: 11.02.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17,
More informationDynamic Spinal Visualization and Vertebral Motion Analysis
Dynamic Spinal Visualization and Vertebral Motion Analysis Policy Number: 6.01.46 Last Review: 2/2019 Origination: 2/2006 Next Review: 2/2020 Policy Blue Cross and Blue Shield of Kansas City (Blue KC)
More informationClinical Policy Title: Room humidifiers
Clinical Policy Title: Room humidifiers Clinical Policy Number: 17.02.05 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review Date:
More informationClinical Policy Title: Epidermal nerve fiber density testing
Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: 09.01.12 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19,
More informationWE MUSCULOSKELETAL SYSTEM. ORTHOPAEDICS
WE MUSCULOSKELETAL SYSTEM. ORTHOPAEDICS For all paediatric orthopaedics see WS430 1 Societies 11 History 13 Dictionaries. Encyclopaedias. Bibliographies Use for general works only. Classify with specific
More informationMedStar Health considers Cough Assist Devices medically necessary for the following indications:
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.047.MH Cough Assist Devices This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar CareFirst
More informationPhysical Therapist Assistant Principles of Neuromuscular Rehabilitation
Western Technical College 10524144 Physical Therapist Assistant Principles of Neuromuscular Rehabilitation Course Outcome Summary Course Information Description Career Cluster Instructional Level Total
More informationAcademic Coursework Preceding Clinical Experience III: PT 675
BIO 639 Human Gross Anatomy (6) This is a lecture and laboratory course in human gross anatomy, which uses cadaver dissection and other materials illustrative of human anatomy. Emphasisis placed on the
More informationClinical Policy Title: Outpatient diabetes self-management training (DSMT)
Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Number: 06.02.02 Effective Date: July 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: March
More informationClinical Policy Title: Platelet rich plasma
Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review
More informationSlide 1. Slide 2. Slide 3. Intro to Physical Therapy for Neuromuscular Conditions. PT Evaluation. PT Evaluation
Slide 1 Intro to Physical Therapy for Neuromuscular Conditions PTA 103 Introduction to Clinical Practice 2 Slide 2 Mental status: consciousness, attention, orientation, cognition Communication: speech
More informationUltrasound and Fluoroscopic Paravertebral Facet Joint Injections
Policy Number FAC06222011RP Ultrasound and Fluoroscopic Approved By UnitedHealthcare Medicare Committee Current Approval Date 06/25/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable
More informationThe Ultimate Biomechanics Lab
myometricslab The Ultimate Biomechanics Lab ASSESSED, QUANTIFIED & VERIFIED Noraxon USA provides market-leading technology for measurement and training devices, such as EMG, gait analysis, biofeedback,
More informationClinical Policy Title: Ambulatory and video electroencephalogram (AEEG, VEEG)
Clinical Policy Title: Ambulatory and video electroencephalogram (AEEG, VEEG) Clinical Policy Number: 09.01.05 Effective Date: October 1, 2014 Initial Review Date: March 19, 2014 Most Recent Review Date:
More informationClinical Policy Title: Genetic testing for Alzheimer s disease
Clinical Policy Title: Genetic testing for Alzheimer s disease Clinical Policy Number: 02.01.20 Effective Date: July 1, 2016 Initial Review Date: May 18, 2016 Most Recent Review Date: May 19, 2017 Next
More informationPhysical Therapy DPT Curriculum Hunter College (Effective Spring 2016)
Summer, Year # 1 (8 weeks) Physical Therapy DPT Curriculum Hunter College (Effective Spring 2016) (Includes new course numbering effective Spring 2016 and new course naming effective Spring 2018) Course
More informationMUSCULOSKELETAL AND NEUROLOGICAL DISORDERS
MUSCULOSKELETAL AND NEUROLOGICAL DISORDERS There are a wide variety of Neurologic and Musculoskeletal disorders which can impact driving safety. Impairment may be the result of altered muscular, skeletal,
More informationConfigure for Diverse
Configure for Diverse Clinical Needs Foot Drop Lower Cuff Foot Drop & Knee Instability Lower & Thigh Cuffs Pediatric Foot Drop Small Lower Cuff Foot Sensor: required for gait Knee Instability & Thigh Weakness
More informationClinical Policy: Robotic Surgery Reference Number: CP.MP. 207
Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207 Effective Date: 03/05 Last Review Date: 10/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important
More informationClinical Policy Title: Investigational (experimental) health services
Clinical Policy Title: Investigational (experimental) health services Clinical Policy Number: 18.04.03 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: September
More informationClinical Policy Title: Tactile breast imaging
Clinical Policy Title: Tactile breast imaging Clinical Policy Number: 05.01.07 Effective Date: February 1, 2018 Initial Review Date: November 16, 2017 Most Recent Review Date: January 11, 2018 Next Review
More informationClinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)
Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most
More informationSympathetic Electrical Stimulation Therapy for Chronic Pain
Sympathetic Electrical Stimulation Therapy for Chronic Pain Policy Number: 015M0076A Effective Date: April 01, 015 RETIRED 5/11/017 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION COVERAGE
More informationGait Analysis Archived Medical Policy
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationIII. Based upon our criteria and review of the peer-reviewed literature, NMES has not been proven to be effective and is
MEDICAL POLICY SUBJECT: NEUROMUSCULAR ELECTRICAL PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationCURRICULUM VITAE. Section Chief, Orthopaedics, Egleston Children s Hospital DATES
CURRICULUM VITAE Revised: October 2012 Name: Robert Wallace Bruce, Jr., M.D. Office Address: Emory Orthopaedic and Spine Center 59 Executive Park South Atlanta, Ga 30329 404-778-3350 Fax: 404-778-3835
More informationMedical Affairs Policy
Service: Acupuncture Therapy PUM 250-0002-1803 Medical Affairs Policy Medical Policy Committee Approval 03/16/18 Effective Date 07/01/18 Prior Authorization Needed Yes-if not an exclusion of the health
More informationClinical Policy Title: Seasonal influenza testing
Clinical Policy Title: Seasonal influenza testing Clinical Policy Number: 07.01.08 Effective Date: October 1, 2017 Initial Review Date: August 17, 2017 Most Recent Review Date: September 21, 2017 Next
More informationClinical Policy Title: Spinal cord stimulators for chronic pain
Clinical Policy Title: Spinal cord stimulators for chronic pain Clinical Policy Number: 03.03.01 Effective Date: October 1, 2014 Initial Review Date: March 19, 2014 Most Recent Review Date: April 19, 2017
More informationChild Neurology Elective PL1 Rotation
PL1 Rotation The neurology elective is available to first year residents in either a 2 or 4 week block rotation. The experience will include performing inpatient consultations, attending outpatient clinics
More informationPayment Policy. Chiropractic Care. Policy Specific Section: September 10, 2012 November 10, 2012
Payment Policy Chiropractic Care Type: Payment Policy Policy Specific Section: Payment Original Policy Date: Effective Date: September 10, 2012 November 10, 2012 Description Chiropractic is a branch of
More informationClinical Policy Title: Epidermal nerve fiber density testing
Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: CCP.1263 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 2, 2018
More informationChiari malformations. A fact sheet for patients and carers
A fact sheet for patients and carers Chiari malformations This fact sheet provides information on Chiari malformations. It focuses on Chiari malformations in adults. Our fact sheets are designed as general
More informationRatified by: Care and Clinical Policies Date: 17 th February 2016
Clinical Guideline Reference Number: 0803 Version 5 Title: Physiotherapy guidelines for the Management of People with Multiple Sclerosis Document Author: Henrieke Dimmendaal / Laura Shenton Date February
More informationClinical Policy Title: Treatment of leg length discrepancy
Clinical Policy Title: Treatment of leg length discrepancy Clinical Policy Number: 14.03.03 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January 18, 2017
More informationUTILIZING CPT AND HCPCS CODES FOR HEALTHCARE REIMBURSEMENT: A guide to billing and reimbursement of SpiderTech kinesiology tape products
UTILIZING CPT AND HCPCS CODES FOR HEALTHCARE REIMBURSEMENT: A guide to billing and reimbursement of SpiderTech kinesiology tape products Billing and coding of taping and strapping services can be a complex
More informationClinical Policy Title: Inhaled nitric oxide
Clinical Policy Title: Inhaled nitric oxide Clinical Policy Number: 11.02.02 Effective Date: June 1 2014 Initial Review Date: February 19, 2014 Most Recent Review Date: May 17, 2017 Next Review Date: March
More informationDELINEATION OF PRIVILEGES - REHABILITATION MEDICINE
KALEIDA HEALTH Name ABMS Board DELINEATION OF PRIVILEGES - REHABILITATION MEDICINE Certification: Please circle all that apply: Board Qualified: Inpatient Rehab Care: Admitting Privileges** (**e: Admitting
More informationClinical Policy Title: Radiofrequency ablation treatment for spine pain
Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Number: 03.02.02 Effective Date: June 1, 2013 Initial Review Date: March 21, 2013 Most Recent Review Date: February
More informationA Gillette Center of Excellence. Center for Gait and Motion Analysis. at Gillette Children s Specialty Healthcare
A Gillette Center of Excellence Center for Gait and Motion Analysis at Gillette Children s Specialty Healthcare Centers of Excellence at Gillette Children s Specialty Healthcare Treating people who have
More informationClinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation
Clinical Policy Title: Noninvasive tests for rejection surveillance after heart transplantation Clinical Policy Number: 04.01.04 Effective Date: January 1, 2016 Initial Review Date September 16, 2015 Most
More informationCourse Descriptions for Courses in the Entry-Level Doctorate in Occupational Therapy Curriculum
Course Descriptions for Courses in the Entry-Level Doctorate in Occupational Therapy Curriculum Course Name Therapeutic Interaction Skills Therapeutic Interaction Skills Lab Anatomy Surface Anatomy Introduction
More informationNZQA Expiring unit standard 7026 version 4 Page 1 of 7. Apply knowledge of functional anatomy and biomechanics
Page 1 of 7 Title Apply knowledge of functional anatomy and biomechanics Level 5 Credits 5 Purpose People credited with this unit standard are able to: apply knowledge of human anatomy relevant to exercise
More information19S0074 The Basics of Sacroiliac Mobilization 5/18/2019 5/18/2020 OnSite 16.5 Great Lakes Seminars
19S0001 19S0023 19S0010 Integrating Peer Review into Your Practice 1/1/2019 1/1/2020 Home Study 5 American Physical Therapy Association 703-706-3130 Fundamental Strength: An Updated Approach to Exercising
More informationClinical Policy Title: Tumor treatment fields for glioblastoma
Clinical Policy Title: Tumor treatment fields for glioblastoma Clinical Policy Number: 05.02.05 Effective Date: July 1, 2015 Initial Review Date: March 18, 2015 Most Recent Review Date: April 19, 2017
More informationPHYSICAL THERAPY. RC K PART 1 Florence Kendall's Muscle testing Trunk and hip muscles (length tests)
PHYSICAL THERAPY RC 925.7.K46 1987 PART 1 Trunk and hip muscles (length tests) RC 925.7.K46 1987 PART 2 Trunk and hip (strength tests) RC 925.7.K46 1987 PART 3 Shoulder joint and shoulder girdle muscles
More informationNeurostimulator Devices and Supplies
Neurostimulator Devices and Supplies Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................
More informationCentral nervous system
Central nervous system By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 7 th Lecture Lecture outline Review of structure & function. Symptoms, signs & tests. Specific diseases. Review of structure
More informationTHE NEUROSCIENCE INSTITUTE OF NEW YORK HOSPITAL QUEENS
THE NEUROSCIENCE INSTITUTE OF NEW YORK HOSPITAL QUEENS PROVIDING A HIGHER LEVEL OF COMPREHENSIVE CARE OF THE BRAIN AND NERVOUS SYSTEM. RIGHT HERE. IN QUEENS. The Neuroscience Institute is The Center for
More informationBiofeedback as a Treatment of Headache
Biofeedback as a Treatment of Headache Policy Number: 2.01.29 Last Review: 7/2018 Origination: 7/2008 Next Review: 7/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) may provide coverage
More informationClinical Policy Title: Arthroscopic anterior cruciate ligament surgery skeletally immature
Clinical Policy Title: Arthroscopic anterior cruciate ligament surgery skeletally immature Clinical Policy Number: 14.03.08 Effective Date: May 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review
More information